Pharmaceutical Market Europe • May 2024 • 5

CONTENTS

May 2024

NEWS & COLUMNS


6-7 NEWS
J&J acquires Shockwave for $13.1bn; Roche shares positive results for Ocrevus in MS

8-9 NEWS
Novartis’ Kymriah recommended by NICE; AstraZeneca to withdraw COVID-19 vaccine

10-11 DERMATOLOGY NEWS
AbbVie's results for Rinvoq in atopic dermatitis; Typharm’s Nystaform advised for skin infections

12 DARWIN'S MEDICINE
The evolution of hype

13 POLICY AND PUBLIC HEALTH
A clear and present danger

14 THE CONSTANCY OF CHANGE
Creating the right mindset

15 INNOVATIVE IMPACT BLOG
Six behaviours of authentic change leaders

FEATURES


16-17 WOMEN IN PHARMA
Iona Everson from PMGroup spoke to Ioana Parsons, general manager of Ipsen UK and Ireland, about her career path and her experiences working in pharma

20-21 ARE AUTOANTIBODIES THE FUTURE OF RA TREATMENT?
The range of available treatments for people living with rheumatoid arthritis has expanded markedly thanks to our increasing understanding of disease pathophysiology

25-35 CELEBRATING COMMUNICATIONS EXCELLENCE
With the landscape of healthcare communications constantly evolving, this special feature explores the most important topics affecting the industry today, from AI to sustainability

COMMUNIQUE
MARKETING & COMMS


36-38 CHASING THE ALCHEMY OF TRIAL DIVERSITY
Industry needs to follow functional realignment to empower a culture change

41-43 THE LANDSCAPE OF HEALTHCARE AND TECHNOLOGY
How choosing market entry in one country over another can impact the success of your medical device

44-45 DRIVING DIVERSITY IN CLINICAL RESEARCH
The positive impact of technology-enabled trials in ensuring equal representation for all

49 HEALTHCARE COMMS
Fox&Cat relaunches; Uptake receives King’s Award for Enterprise

CAREERS & RECRUITMENT


46-48 APPOINTMENTS
Changes at Gilead, UCB and Chiesi

51 PHARMA MARKETING JOBS
Visit our new website for all your recruiting needs!

0